Stock listing
NASDAQ:VIR Vir Biotechnology, Inc. Stock
Home listing (NASDAQ) of Vir Biotechnology, Inc.
Follow Vir Biotechnology, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VIR
$10.77 USD +0.56 (+5.5%)
Delayed at least 15 minutes · 1:59 PM EDT, Oct 20, 2026
- Day range so far
- $10.14 – $10.83 USDDelayed at least 15 minutes · 1:59 PM EDT, Oct 20, 2026
- Volume
- 811,044 sharesDelayed at least 15 minutes · 1:59 PM EDT, Oct 20, 2026
- Market cap
- $1.82B USDDelayed at least 15 minutes · 1:59 PM EDT, Oct 20, 2026 · price × 169.2M shares outstanding
- 52-week range
- $4.82 – $12.00 USDLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VIR · Home | $10.77 USD | +0.56 (+5.5%) | 811,044 | $10.19 | $10.83 | $10.14 | $10.21 | Delayed 15+ min · 1:59 PM EDT, Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:VIR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.21 | +0.25 | +2.5% | $10.07 | $10.30 | $9.96 | 1,309,172 | |
| $9.96 | -0.51 | -4.9% | $10.49 | $10.49 | $9.91 | 1,735,300 | |
| $10.47 | +0.06 | +0.6% | $10.38 | $10.67 | $10.20 | 1,417,900 | |
| $10.41 | -0.20 | -1.9% | $10.95 | $11.11 | $10.34 | 2,764,900 | |
| $10.61 | -0.69 | -6.1% | $11.21 | $11.25 | $10.60 | 1,783,600 | |
| $11.30 | -0.40 | -3.4% | $11.63 | $11.82 | $11.21 | 1,086,200 | |
| $11.70 | +0.58 | +5.2% | $11.11 | $12.00 | $10.97 | 1,965,100 | |
| $11.12 | -0.40 | -3.5% | $11.52 | $11.56 | $10.73 | 3,071,100 | |
| $11.52 | -0.08 | -0.7% | $11.32 | $11.77 | $11.32 | 3,561,900 | |
| $11.60 | -0.18 | -1.5% | $11.90 | $11.90 | $11.26 | 2,586,700 | |
| $11.78 | +0.61 | +5.5% | $11.17 | $11.87 | $10.92 | 3,147,200 | |
| $11.17 | -0.12 | -1.1% | $11.55 | $11.73 | $10.95 | 2,180,600 | |
| $11.29 | +0.11 | +1.0% | $10.86 | $11.61 | $10.86 | 2,575,800 | |
| $11.18 | +0.53 | +5.0% | $10.70 | $11.26 | $10.54 | 1,737,500 | |
| $10.65 | +0.14 | +1.3% | $10.49 | $10.85 | $10.34 | 1,573,700 | |
| $10.51 | -0.15 | -1.4% | $10.56 | $10.69 | $10.33 | 1,369,900 | |
| $10.66 | -0.06 | -0.6% | $10.82 | $10.82 | $10.48 | 1,126,000 | |
| $10.72 | -0.37 | -3.3% | $11.02 | $11.16 | $10.35 | 2,085,200 | |
| $11.09 | -0.41 | -3.6% | $11.44 | $11.53 | $10.85 | 1,684,800 | |
| $11.50 | +0.62 | +5.7% | $10.99 | $11.72 | $10.89 | 1,852,000 | |
| $10.88 | +0.28 | +2.6% | $10.77 | $10.95 | $10.66 | 1,454,900 | |
| $10.60 | -0.32 | -2.9% | $10.92 | $11.00 | $10.44 | 7,017,200 | |
| $10.92 | +0.40 | +3.8% | $10.87 | $11.21 | $10.68 | 1,791,300 | |
| $10.52 | +0.08 | +0.8% | $10.54 | $10.67 | $10.39 | 2,091,100 | |
| $10.44 | -0.325 | -3.0% | $10.71 | $10.73 | $10.23 | 2,282,200 | |
| $10.77 | +0.145 | +1.4% | $10.73 | $10.94 | $10.64 | 1,841,500 | |
| $10.62 | +0.04 | +0.4% | $10.79 | $10.95 | $10.38 | 2,078,000 | |
| $10.58 | -0.23 | -2.1% | $10.57 | $10.79 | $10.45 | 1,855,300 | |
| $10.81 | -0.37 | -3.3% | $11.04 | $11.38 | $10.74 | 1,945,600 | |
| $11.18 | -0.205 | -1.8% | $11.22 | $11.28 | $10.99 | 1,613,900 | |
| $11.39 | -0.065 | -0.6% | $11.31 | $11.65 | $11.18 | 1,151,300 | |
| $11.45 | -0.05 | -0.4% | $11.54 | $11.62 | $11.07 | 2,565,400 | |
| $11.50 | -0.13 | -1.1% | $11.63 | $11.94 | $11.35 | 3,019,800 | |
| $11.63 | +0.69 | +6.3% | $10.80 | $11.74 | $10.80 | 2,778,100 | |
| $10.94 | +0.11 | +1.0% | $10.77 | $11.17 | $10.65 | 3,046,500 | |
| $10.83 | -0.48 | -4.2% | $11.16 | $11.46 | $10.80 | 1,835,200 | |
| $11.31 | +0.23 | +2.1% | $11.00 | $11.46 | $10.84 | 1,737,300 | |
| $11.08 | +0.37 | +3.5% | $10.60 | $11.12 | $10.30 | 2,248,500 | |
| $10.71 | +0.80 | +8.1% | $10.03 | $11.28 | $9.97 | 2,961,369 | |
| $9.91 | +0.13 | +1.3% | $9.74 | $9.975 | $9.435 | 1,739,718 | |
| $9.78 | +0.57 | +6.2% | $9.31 | $9.86 | $9.305 | 1,756,400 | |
| $9.21 | -0.56 | -5.7% | $9.61 | $9.71 | $9.025 | 1,060,400 | |
| $9.77 | +0.28 | +3.0% | $9.86 | $10.08 | $9.54 | 2,085,700 | |
| $9.49 | +0.10 | +1.1% | $9.27 | $9.50 | $9.24 | 1,480,800 | |
| $9.39 | +0.15 | +1.6% | $9.23 | $9.49 | $9.17 | 1,460,800 | |
| $9.24 | +0.24 | +2.7% | $9.00 | $9.27 | $8.80 | 1,016,300 | |
| $9.00 | +0.04 | +0.4% | $9.02 | $9.20 | $8.883 | 1,246,300 | |
| $8.96 | +0.03 | +0.3% | $8.89 | $9.09 | $8.855 | 984,200 | |
| $8.93 | +0.04 | +0.4% | $8.96 | $9.01 | $8.771 | 1,203,155 | |
| $8.89 | +0.07 | +0.8% | $8.80 | $9.03 | $8.79 | 1,487,216 | |
| $8.82 | +0.055 | +0.6% | $8.87 | $9.03 | $8.75 | 1,663,100 | |
| $8.765 | -0.345 | -3.8% | $9.699 | $9.699 | $8.615 | 2,602,600 | |
| $9.11 | -0.06 | -0.7% | $9.19 | $9.36 | $9.00 | 1,452,600 | |
| $9.17 | +0.27 | +3.0% | $9.02 | $9.275 | $8.93 | 1,708,600 | |
| $8.90 | +0.24 | +2.8% | $8.91 | $9.06 | $8.545 | 1,241,300 | |
| $8.66 | -0.24 | -2.7% | $8.95 | $8.96 | $8.535 | 1,126,900 | |
| $8.90 | +0.26 | +3.0% | $8.61 | $8.995 | $8.61 | 1,197,400 | |
| $8.64 | -0.21 | -2.4% | $8.84 | $8.97 | $8.55 | 1,412,800 | |
| $8.85 | +0.05 | +0.6% | $8.83 | $8.885 | $8.52 | 1,391,400 | |
| $8.80 | +0.11 | +1.3% | $8.82 | $9.085 | $8.77 | 1,687,800 | |
| $8.69 | -0.65 | -7.0% | $9.00 | $9.15 | $8.62 | 2,151,300 | |
| $9.34 | -0.01 | -0.1% | $9.21 | $9.467 | $9.16 | 1,514,500 | |
| $9.35 | -0.07 | -0.7% | $9.38 | $9.59 | $9.30 | 1,451,600 | |
| $9.42 | +0.19 | +2.1% | $9.20 | $9.555 | $9.14 | 1,731,600 | |
| $9.23 | -0.20 | -2.1% | $9.40 | $9.585 | $9.11 | 1,475,200 |
- Ticker
- NASDAQ:VIR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
Latest earnings call · Aug 5, 2026
Vir Biotechnology (NASDAQ:VIR) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 5, 2026
Q2 2026 Earnings Presentation
Earnings · 62 slides
Calls
Replays
Vir Biotechnology (NASDAQ:VIR) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptVir Biotechnology (NASDAQ:VIR) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch TranscriptVir Biotechnology (NASDAQ:VIR) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 5:30 PM ET
Watch Transcript
Latest news
Vir Biotechnology Enters Multi-Program Collaboration and License Agreement with Gilead Sciences to Discover and Develop Novel PRO-XTEN® Dual-masked T-cell Engagers for Solid Tumors
Oct 14, 2026
Closed $10.41 (-1.9%) on Oct 14, 2026
Vir Biotechnology Announces PSMA-targeted PRO-XTEN® Dual-masked T-cell Engager VIR-5500 Received FDA Fast Track Designation for the Treatment of Prostate Cancer
Oct 8, 2026
Closed $11.12 (-3.5%) on Oct 8, 2026
Vir Biotechnology Appoints David Liu as Chief Medical Officer
Oct 7, 2026
Closed $11.52 (-0.7%) on Oct 7, 2026
Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026
Oct 5, 2026
Closed $11.60 (-1.5%) on Oct 6, 2026
Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer
Oct 1, 2026
Closed $11.29 (+1.0%) on Oct 1, 2026
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Aug 31, 2026
Closed $11.63 (+6.3%) on Sep 1, 2026
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug 5, 2026
Closed $8.77 (-3.8%) on Aug 6, 2026
Vir Biotechnology Announces Chief Financial Officer Transition
Jul 24, 2026
Closed $8.69 (-7.0%) on Jul 24, 2026
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
Jul 22, 2026
Closed $9.34 (-0.1%) on Jul 23, 2026
Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
Jun 10, 2026
Closed $8.52 (+3.3%) on Jun 11, 2026
Financings
Strategic investment of equity
Oct 14, 2026
Announced: US$25M
Buyers: Gilead ($25 million equity investment at a 30% premium)
Decks
Q2 2026 Earnings Presentation
Earnings · 62 slides · Aug 5, 2026
Technical Presentation (May 2026)
Technical · 10 slides · May 6, 2026
Q1 2026 Earnings Presentation
Earnings · 61 slides · May 6, 2026
Q4 2025 Earnings Presentation
Earnings · 56 slides · Feb 23, 2026
Vir Biotechnology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 237 in all · newest Oct 14, 2026 · oldest 2019
- Calls
- 13 calls with a replay · 13 with a transcript · latest Aug 5, 2026
- Decks
- 29 decks · latest Aug 5, 2026
Where Vir Biotechnology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VIR · Home listing · This page | NASDAQ | United States | USD |
| BMV:VIR | BMV | Mexico | MXN |
| BIVA:VIR | BIVA | Mexico | MXN |
| BX Swiss:VIR | BX Swiss | Switzerland | CHF |
| BOATS:VIR | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Vir Biotechnology, Inc.